{
  "trial_id": "NCT02109029",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of Type 1 Diabetes Mellitus, c-peptide value, serum creatinine value, haemoglobin A1c (HbA1c) value, body mass index (BMI), fasting triglycerides value, total daily insulin dose, blood pressure, renal function, presence of proliferative retinopathy or maculopathy, presence of lipodystrophy, wound healing status, prothrombin time (PT), international normalized ratio (INR), use of glucocorticoids, use of medications affecting blood glucose, use of non-selective beta blockers, use of monoamine oxidase (MAO) inhibitors, participation in weight loss programs, sun exposure habits, consumption of food containing inulin.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "BMI",
          "body mass index (BMI)"
        ],
        [
          "HbA1c",
          "haemoglobin A1c (HbA1c) value"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "duration of Type 1 Diabetes Mellitus",
        "c-peptide value",
        "serum creatinine value",
        "fasting triglycerides value",
        "total daily insulin dose",
        "blood pressure",
        "renal function",
        "presence of proliferative retinopathy or maculopathy",
        "presence of lipodystrophy",
        "wound healing status",
        "prothrombin time (PT)",
        "international normalized ratio (INR)",
        "use of glucocorticoids",
        "use of medications affecting blood glucose",
        "use of non-selective beta blockers",
        "use of monoamine oxidase (MAO) inhibitors",
        "participation in weight loss programs",
        "sun exposure habits",
        "consumption of food containing inulin"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Mass Index, HbA1c, Serum Creatinine, C-peptide, Total Daily Insulin Dose, Fasting Triglycerides, Blood Pressure,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "BMI",
          "Body Mass Index"
        ],
        [
          "HbA1c",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Serum Creatinine",
        "C-peptide",
        "Total Daily Insulin Dose",
        "Fasting Triglycerides",
        "Blood Pressure"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Diabetes Diagnosis Duration, BMI, HbA1c, C-peptide, Serum Creatinine, Haemoglobin, Body Mass Index, Total Daily Insulin Dose, Fasting Triglycerides.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "BMI",
          "BMI"
        ],
        [
          "HbA1c",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "Diabetes Diagnosis Duration",
        "C-peptide",
        "Serum Creatinine",
        "Haemoglobin",
        "Body Mass Index",
        "Total Daily Insulin Dose",
        "Fasting Triglycerides"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), haemoglobin A1c (HbA1c), c-peptide, serum creatinine, fasting triglycerides, total daily insulin dose, duration of type 1 diabetes mellitus (T1DM), history of diabetic complications (e.g. proliferative retinopathy, maculopathy, lipodystrophy).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "BMI",
          "body mass index (BMI)"
        ],
        [
          "HbA1c",
          "haemoglobin A1c (HbA1c)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "c-peptide",
        "serum creatinine",
        "fasting triglycerides",
        "total daily insulin dose",
        "duration of type 1 diabetes mellitus (T1DM)",
        "history of diabetic complications (e.g. proliferative retinopathy, maculopathy, lipodystrophy)."
      ]
    }
  }
}